Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver

NCT00324727 is registered in ClinicalTrials.gov with Delcath Systems Inc. as lead sponsor.

NCT NCT00324727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00324727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver
Lead sponsor
Delcath Systems Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
August 31, 2012
Enrollment
93 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

intraocular melanoma, melanoma (skin), metastatic cancer